Skip to content

Our publications

Since its inception, Inovarion has contributed to the completion of high-level research projects. Our scientists have actively participated to studies resulting in publications in prestigious, high-impact journals. These publications span a wide range of fields within biology, driving innovation and fostering progress across numerous therapeutic and scientific domains.

See all on Pubmed
Filter :
Oncoimmunology
Oncology

License to kill: microsatellite instability and immune contexture

Learn more
Cancers (Basel)
Oncology

Cooperative Blockade of CK2 and ATM Kinases Drives Apoptosis in VHL-Deficient Renal Carcinoma Cells through ROS Overproduction

Learn more
J Clin Oncol.
Oncology

Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer

Learn more
Oncoimmunology
Oncology

Immunity to live: an immunopathoscore using the consensus Immunoscore to best define the risk of recurrence and death in stage IV metastatic patients

Learn more
Trends in molecular medicine
Oncology

Predicting and Overcoming Taxane Chemoresistance

Learn more
Oncoimmunology
Oncology

Multiverse of immune microenvironment in metastatic colorectal cancer

Learn more
The journal of pathology
Oncology

Prognostic assessment of resected colorectal liver metastases integrating pathological features, RAS mutation and Immunoscore

Learn more
Oncoimmunology
Oncology

Metastasis immune-based scores predict patient survival

Learn more
Scientific Reports
Oncology

ATIP3 deficiency facilitates intracellular accumulation of paclitaxel to reduce cancer cell migration and lymph node metastasis in breast cancer patients

Learn more
Strahlenther Onkol .
Oncology

Systemic modulation of stress and immune parameters in patients treated for prostate adenocarcinoma by intensity-modulated radiation therapy or stereotactic ablative body radiotherapy

Learn more
Scientific Reports
Oncology

Extracellular vesicles produced by NFAT3-expressing cells hinder tumor growth and metastatic dissemination

Learn more
JNCI Cancer spectrum
Oncology

Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer

Learn more